GemPharmatech Co., Ltd. (SHA:688046)

GemPharmatech Statistics

Total Valuation

GemPharmatech has a market cap or net worth of CNY 6.98 billion. The enterprise value is 6.11 billion.

Market Cap	6.98B
Enterprise Value	6.11B

Important Dates

The next estimated earnings date is Thursday, April 23, 2026.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	Nov 20, 2025

Share Statistics

GemPharmatech has 410.00 million shares outstanding. The number of shares has increased by 1.43% in one year.

Current Share Class	410.00M
Shares Outstanding	410.00M
Shares Change (YoY)	+1.43%
Shares Change (QoQ)	+10.91%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	15.90%
Float	161.79M

Valuation Ratios

The trailing PE ratio is 48.63 and the forward PE ratio is 45.59.

PE Ratio	48.63
Forward PE	45.59
PS Ratio	8.80
PB Ratio	3.17
P/TBV Ratio	3.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	42.29
EV / Sales	7.70
EV / EBITDA	25.73
EV / EBIT	37.11
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.15
Debt / EBITDA	1.38
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 6.66% and return on invested capital (ROIC) is 10.87%.

Return on Equity (ROE)	6.66%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	10.87%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	7.39%
Revenue Per Employee	502,696
Profits Per Employee	91,507
Employee Count	1,578
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, GemPharmatech has paid 19.96 million in taxes.

Income Tax	19.96M
Effective Tax Rate	12.14%

Stock Price Statistics

The stock price has increased by +10.95% in the last 52 weeks. The beta is 0.63, so GemPharmatech's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	+10.95%
50-Day Moving Average	16.86
200-Day Moving Average	15.96
Relative Strength Index (RSI)	43.64
Average Volume (20 Days)	3,678,637

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GemPharmatech had revenue of CNY 793.25 million and earned 144.40 million in profits. Earnings per share was 0.35.

Revenue	793.25M
Gross Profit	793.25M
Operating Income	164.55M
Pretax Income	164.36M
Net Income	144.40M
EBITDA	237.34M
EBIT	164.55M
Earnings Per Share (EPS)	0.35

Balance Sheet

The company has 1.20 billion in cash and 327.40 million in debt, with a net cash position of 871.09 million or 2.12 per share.

Cash & Cash Equivalents	1.20B
Total Debt	327.40M
Net Cash	871.09M
Net Cash Per Share	2.12
Equity (Book Value)	2.20B
Book Value Per Share	5.37
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 20.74% and 18.20%.

Gross Margin	100.00%
Operating Margin	20.74%
Pretax Margin	20.72%
Profit Margin	18.20%
EBITDA Margin	29.92%
EBIT Margin	20.74%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 0.82%.

Dividend Per Share	0.14
Dividend Yield	0.82%
Dividend Growth (YoY)	-26.32%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.43%
Shareholder Yield	-0.63%
Earnings Yield	2.07%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2